US Stem Cell us-stemcell.com


US Stem Cell is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.

US Stem Cell is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.

Company (IPO / Went public)

Phone: 954-835-1500

Fax:

1560 Sawgrass Corporate Parkway
4th Floor
Sunrise, 33323
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
US Stem Cell $43M Feb 20, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related US Stem Cell Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Cardioxyl Pharmaceuticals

Chapel Hill, North Carolina, United States
AcquiredCardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed solutions in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinic...Show allLogin to see details

Inflazyme Pharmaceuticals

British Columbia, Canada
Alive / ActiveInflazyme Pharmaceuticals Ltd. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and inflammatory diseases. The company's core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of enhancing myogenesis by electrical stimulation Mar 28, 2005 Jan 27, 2009 Patent